Recruiting OBSERVATIONAL NCT03005132

Integrative Analysis of Human Glioblastoma Multiforme

Sponsor: Ganzhou City People's Hospital

Conditions GBM

Updated 5 times since 2017 Last updated: Dec 23, 2016 Started: Jan 31, 2016 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03005132, this observational or N/A phase trial focuses on GBM and remains actively recruiting participants. Sponsored by Ganzhou City People's Hospital, it has been updated 5 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2021 — Jul 2024 [monthly]

Recruiting
Apr 2018 — Jan 2021 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ganzhou City People's Hospital
Jilin University
Shanghai 10th People's Hospital

Data source: Shanghai 10th People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China